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1167A Combined Optical Coherence Tomography and
Intravascular Ultrasound Study on Plaque Rupture,
Plaque Erosion, and Calciﬁed Nodule in Patients With
ST-Segment Elevation Myocardial InfarctionIncidence, Morphologic Characteristics, and Outcomes After
Percutaneous Coronary InterventionABSTRACTOBJECTIVES This study sought to evaluate the incidence of plaque rupture (PR), plaque erosion (PE), and calciﬁed
nodule (CN) using optical coherence tomography (OCT) in patients with ST-segment elevation myocardial infarction
(STEMI); to compare detailed morphologic plaque characteristics of PR, PE, and CN with optical coherence tomography
and intravascular ultrasound; and to compare the post-procedure outcomes among PR, PE, and CN.
BACKGROUND The incidence and detailed morphologic characteristics of PR, PE, and CN in STEMI patients and their
outcome after percutaneous coronary intervention (PCI) are unknown.
METHODS A total of 112 STEMI patients who underwent PCI within 12 h from symptom onset were included. Both
optical coherence tomography and intravascular ultrasound were performed following aspiration thrombectomy.
RESULTS The incidence of PR, PE, and CN was 64.3%, 26.8%, and 8.0%, respectively. PE and CN, compared with PR,
had more ﬁbrous plaque (p < 0.001 and p < 0.001) and less thin-cap ﬁbroatheroma (p < 0.001 and p < 0.001) as well
as smaller plaque burden (p ¼ 0.003 and p ¼ 0.001) and remodeling index (p ¼ 0.003 and p < 0.001). PE had greater
plaque eccentricity index than PR and CN (p < 0.001 and p < 0.001). CN had greater calciﬁed arc and shallower calcium
than PR (p < 0.001 and p < 0.001) or PE (p < 0.001 and p < 0.001). More than one-half of CN had negative remodeling.
PE had a lower incidence of no-reﬂow phenomenon after PCI than PR (p ¼ 0.011).
CONCLUSIONS PE was the underlying mechanism in one-fourth of STEMI. PE was characterized by eccentric ﬁbrous
plaque. CN was characterized by superﬁcial large calcium and negative remodeling. PE was associated with less micro-
vascular damage after PCI. (J Am Coll Cardiol Intv 2015;8:1166–76) © 2015 by the American College of Cardiology
Foundation.SEE PAGE 1177
T he majority of acute coronary thromboses areattributable to 3 underlying mechanisms:plaque rupture (PR); plaque erosion (PE);
and calciﬁed nodule (CN). PR has been well character-
ized by both ex vivo and in vivo studies (1–3). Our
group recently reported in vivo diagnosis of PE and
CN using optical coherence tomography (OCT) in pa-
tients with acute coronary syndromes (ACS) (4). In
that study, patients with ST-segment elevation
myocardial infarction (STEMI) and non–ST-segment
elevation ACS were both included, and intravascular
OCT was performed at variable time points after
symptom onset. Therefore, the true incidence of PE
and CN in patients with acute STEMI has not previ-
ously been reported. In addition, information on
plaque burden and coronary remodeling in thispopulation has not been studied because only OCT
was used.The aims of this study were the following: 1) to
evaluate the incidence of PR, PE, and CN detected by
OCT in patients with STEMI during the acute phase; 2)
to study the detailed morphologic characteristics of
the culprit plaques using the combination of OCT and
intravascular ultrasound (IVUS); and 3) to compare
the post-procedure outcomes among these 3 groups.
METHODS
STUDY POPULATION AND PCI PROCEDURES. Of the
145 patients who were admitted to Hirosaki
FIGURE 1 Study Flow Chart
Of the 145 patients with acute o
lying mechanism of STEMI using
for detail analysis. IVUS ¼ intrav
STEMI ¼ ST-segment elevation
ABBR EV I A T I ON S
AND ACRONYMS
ACS = acute coronary
syndrome
CK = creatine kinase
CN = calciﬁed nodule
CSA = cross-sectional area




OCT = optical coherence
tomography
PCI = percutaneous coronary
intervention
PE = plaque erosion
PþM = plaque plus media
PR = plaque rupture
STEMI = ST-segment elevation
myocardial infarction
TIMI = Thrombolysis In
Myocardial Infarction
TCFA = thin-cap ﬁbroather
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STEMI between January 2013 and June 2014
and who provided written informed consent
for the primary percutaneous coronary
intervention (PCI) procedure, 112 patients
who had undergone both OCT and IVUS as
part of their routine care were retrospectively
included in this study (Figure 1). This study
cohort was different from our previous study
(4). We did not include previous data in this
study. STEMI was deﬁned as elevation of
creatine kinase-myocardial isoform and/or
cardiac troponin T value greater than the
upper reference limit with typical chest pain
lasting >20 min, and ECG showing new ST-
segment elevation of $2 mm in at least 2
contiguous precordial electrocardiogram
leads, $1 mm in at least 2 contiguous limb
electrocardiogram leads, or newly appeared
left bundle branch block. All patients under-
went the interventional procedure within 12
h of symptom onset. Exclusion criteria were
cardiogenic shock, unsuccessful reperfusionto achieve antegrade ﬂow after aspiration thrombec-
tomy, in-stent thrombosis, inability to advance an
intravascular imaging catheter to the culprit lesion,
poor image quality, massive thrombus, and coronary
embolism.
All images were deidentiﬁed, digitally stored, and
sent to Massachusetts General Hospital (Boston). All
image analysis was performed at Massachusetts
General Hospital. Using the previously established
omanset STEMI, 112 patients were identiﬁed with the under-
OCT and IVUS. Finally, 111 STEMI patients were enrolled
ascular ultrasound; OCT ¼ optical coherence tomography;
myocardial infarction.criteria (4), the patients were classiﬁed into 4 groups:
PR; PE; CN; and others. Angiographic, OCT, IVUS, and
patient characteristics were compared among the PR,
PE, and CN groups. This collaboration study was
approved by the institutional review boards at
Massachusetts General Hospital and Hirosaki Uni-
versity Hospital.
ACQUISITION OF OCT AND IVUS IMAGE. Aspirin 200
mg, clopidogrel 300 mg, and heparin 100 IU/kg were
administrated prior to the procedure. None of the
patients were pretreated with a thrombolytic agent
and a glycoprotein IIb/IIIa inhibitor because the
latter agent was not available in Japan. Both OCT
and IVUS were performed to the culprit lesion after
manual thrombectomy, which was repeated until
antegrade coronary ﬂow was restored and analyz-
able image quality was achieved. A frequency-
domain OCT system (ILUMIEN OCT Intravascular
Imaging Systems, St. Jude Medical, St. Paul, Min-
nesota) was used in this study. The technique of
intracoronary OCT imaging has been previously
described (5).
For IVUS imaging, a 20-MHz, 3.2-F catheter (Eagle
Eye Gold Catheter, Volcano Therapeutics, San Diego,
California) was used. After positioning the IVUS
catheter distal to the target lesion, the catheter was
pulled back to the coronary ostium using a motorized
pull-back device at 0.5 mm/s.
OCT ANALYSIS. OCT images from the entire length of
the lesion plus 5 mm proximal and distal reference
segments were included in the analysis. The refer-
ence was the frame showing the largest lumen area
within 10 mm proximal and distal from the target
lesions. Plaques were categorized using the previ-
ously established criteria (4). PR was deﬁned by the
presence of ﬁbrous cap discontinuity with a commu-
nication between lumen and inner core of a plaque or
with a cavity formation within the plaque (Figure 2A)
(3,6). PE was identiﬁed by the presence of attached
thrombus overlying an intact and visualized plaque,
luminal surface irregularity at the culprit lesion in the
absence of thrombus, or attenuation of underlying
plaque by thrombus without superﬁcial lipid or
calciﬁcation immediately proximal or distal to the site
of thrombus (Figure 2B) (4). CN was deﬁned by ﬁbrous
cap disruption detected over a calciﬁed plaque char-
acterized by protruding calciﬁcation, superﬁcial cal-
cium, or the presence of substantive calcium
proximal and/or distal to the lesion (Figure 2C).
Culprit lesions that did not satisfy these criteria were
classiﬁed as others and included tight stenosis,
spontaneous coronary artery dissection, and coronary
spasm.
FIGURE 2 Representative Images of Underlying Plaque Morphologies in STEMI
(A) Plaque rupture: disrupted ﬁbrous cap (white arrows), large lipid core (1 to 10 o’clock),
and spotty calciﬁcation (red arrow) were observed on both OCT and IVUS. (B) Plaque
erosion: OCT demonstrated white thrombus (arrowheads) on the luminal surface. There
was no evidence of ﬁbrous cap disruption. IVUS revealed deep spotty calciﬁcation
(red arrow). (C) Calciﬁed nodule: OCT revealed concave calciﬁcation (white arrow) with
white thrombus (arrowhead). IVUS showed a large calcium sheet near the luminal surface
(red arrows). Abbreviations as in Figure 1.
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1169Tissue characterization of underlying plaque was
performed using previously established criteria (7,8).
Plaques were classiﬁed as primarily ﬁbrous (homo-
geneous, high backscattering region) or lipid (low-
signal region with diffuse border). Lipid plaque was
deﬁned as a plaque with lipid arc >90. For each lipid
plaque, the thinnest ﬁbrous cap thickness and the
maximal arc of lipid were measured. We evaluated
the presence of lipid on every cross section. Addi-
tionally, lipid length was measured using the
consecutive length of cross section with lipid on
longitudinal view. Thin-cap ﬁbroatheroma (TCFA)
was deﬁned as a plaque with lipid arc >90 with
thinnest ﬁbrous cap thickness <65 mm. Calciﬁcation
was deﬁned as a signal-poor or heterogeneous region
with sharply delineated borders. For each calciﬁca-
tion, the maximal calcium arc and the minimal depth
from luminal surface to the leading edge of calciﬁca-
tion were measured. A microchannel was deﬁned as a
sharply delineated signal-poor hole visible on multi-
ple contiguous frames (5,9). Thrombus was semi-
quantitatively calculated by summing the number of
involved quadrants in each 1-mm interval cross sec-
tion (10). All OCT images were analyzed by 2 ex-
perienced investigators who were blinded to the
angiographic data and clinical presentations. When
there was discordance between the observers, a
consensus reading was obtained from another inves-
tigator. Interobserver and intraobserver variability
were assessed by the evaluation of all images by
2 independent observers and by the same observer at
2 separate time points.
IVUS ANALYSIS. Quantitative IVUS measurements
included the external elastic membrane (EEM) cross-
sectional area (CSA), lumen CSA, and the plaque
plus media (PþM) CSA at the lesion site (cross section
with the minimal lumen CSA) and reference sites.
Plaque burden was calculated as the lesion PþM CSA
divided by the lesion EEM CSA multiplied by 100 (11).
Reference site was identiﬁed as the image frame
showing the least diseased site within 10 mm prox-
imal and distal to the culprit lesion. Plaque eccen-
tricity index was calculated as (maximal PþM
thickness minus minimal PþM thickness) divided by
maximal PþM thickness (11), and eccentric plaque
was deﬁned by plaque eccentricity index >0.65. This
threshold value was determined using receiver-
operating characteristic to predict PE. The remodel-
ing index was calculated as the EEM CSA at the lesion
site divided by the average of the proximal and distal
reference EEM CSA (11). Positive remodeling was
deﬁned as plaque with remodeling index >1.05, and
negative remodeling was deﬁned as plaque withremodeling index <0.95. IVUS-detected PR was
deﬁned as plaque ulceration with a tear detected in the
ﬁbrous cap (Figure 2A) (11). All IVUS images were
analyzed by 2 experienced investigators who were
blinded to the angiographic data and clinical pre-
sentations. When there was discordance between the
observers, a consensus reading was obtained from
another investigator.
ANGIOGRAPHIC ANALYSIS. Coronary angiograms
performed before intervention, after thrombectomy,
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We evaluated baseline, post-thrombectomy, and
ﬁnal antegrade coronary ﬂow according to the TIMI
(Thrombolysis In Myocardial Infarction) criteria (12)
and ﬁnal myocardial blush grade (13). No-reﬂow was
deﬁned as TIMI ﬂow grade #2 or TIMI ﬂow grade 3
with myocardial blush grade #1 at the ﬁnal angiogram
(14). Reference diameter, minimal lumen diameter,
percentage of diameter stenosis, and lesion length
were also measured. Coronary angiograms were
analyzed using an off-line quantitative coronary
angiography program (CAAS version 5.10.1, Pie
Medical Imaging BV, Maastricht, the Netherlands).
STATISTICAL ANALYSIS. Categorical outcomes were
presented as counts and percentages, and Fisher
exact test or chi-square test was used as appropriate.
The distributions of continuous variables were tested
for normality with the Kolgormonov-Smirnov test.
The mean  SD was reported when data were nor-
mally distributed, and the median (25th, 75th per-
centiles) were reported when data were not normally
distributed. For between-group comparisons, 1-way
analysis of variance or Kruskal-Wallis test for
continuous outcomes and chi-square or Fisher exact
test for categorical outcomes was applied for testing
overall differences, and then post-hoc tests for con-
trolling type 1 error by using Bonferroni correction
were performed if the overall test was signiﬁcant.
A p value of <0.05 was considered statistically sig-
niﬁcant for an overall comparison. If the p value of
the overall test was <0.05, then 2-group post-hoc
comparison was performed using Mann-Whitney
U test or the independent samples Student t test
for continuous outcomes, and chi-square or Fisher
exact test for categorical outcomes, and the test
result was considered signiﬁcant if the p value
was <0.017 (i.e., 0.05 of 3). Receiver-operating
characteristic analysis was performed to determine
the best cutoff value of plaque eccentricity index for
PE. Intra- and interobserver reliability was assessed
by kappa statistics. All statistical analyses were per-
formed with SPSS (version 17.0, SPSS Inc., Chicago,
Illinois).
RESULTS
PREVALENCE OF PLAQUE RUPTURE, PLAQUE
EROSION, AND CALCIFIED NODULE. In the 112 cases
of STEMI, the prevalence of PR, PE, and CN was
72 (64.3%), 30 (26.8%), and 9 (8.0%), respectively.
Another cause of STEMI included 1 case (0.9%) of
spontaneous coronary dissection. Finally, 111 patients
in which STEMI was caused by PR, PE, or CN wereincluded for morphologic characterization and anal-
ysis. Intraobserver and interobserver kappa co-
efﬁcients for plaque classiﬁcation were 0.85 and 0.87,
respectively.
BASELINE CHARACTERISTICS. The baseline clinical
and angiographic characteristics are shown in
Tables 1 and 2. Patients with PE were younger than
those with CN (p ¼ 0.004) and less frequently obese
than those with PR (p ¼ 0.012). There were no sig-
niﬁcant differences in the other clinical variables
among the 3 groups.
The location of the culprit lesion and angiographic
parameters were similar among the 3 groups. Severe
calciﬁcation was more frequently seen in CN than in
PR (p < 0.001) or PE (p ¼ 0.002). Although PR
required a slightly greater number of stents than PE
did (p ¼ 0.010), stent diameter, total stent length, and
maximal balloon pressure were similar among the
3 groups.
OCT FINDINGS. Both PE and CN, when compared
with PR, had a higher prevalence of ﬁbrous plaque
(p < 0.001 and p < 0.001), and a lower prevalence
of lipid plaque (p < 0.001 and p < 0.001) and TCFA
(p < 0.001 and p < 0.001) (Table 3, Figure 3A and 3B).
Among lipid plaques, PE and CN had smaller lipid
burden than PR did (Table 3).
PE had a lower prevalence of microchannels than
PR did (p < 0.001) (Figure 3C). Although the preva-
lence of calciﬁcation and calcium arc were similar
between PE and PR, the location of calciﬁcation in PE
was deeper in the vessel wall than it was in PR
(p < 0.001) (Table 3).
CN had larger calcium arc and more superﬁcial cal-
cium in the vesselwall than PR (p<0.001 and p<0.001)
or PE (p< 0.001 and p< 0.001) (Table 3). There were no
differences in other OCT characteristics between PE
and CN. Post-thrombectomy thrombus score was
similar among the 3 groups.
IVUS FINDINGS. Among the 72 OCT-detected PR,
IVUS could detect only 17 PR (23.6%). Compared
with PR, PE had larger lumen CSA (p ¼ 0.005),
smaller plaque burden (p ¼ 0.003), and greater pla-
que eccentricity index (p < 0.001) at the lesion site
(Table 4). Receiver-operating characteristic curve
analysis showed that a plaque eccentricity index of
0.65 was the best cutoff to predict PE (area under
the curve: 0.744, sensitivity: 73.3%, speciﬁcity:
70.4%, positive predictive value: 47.8%, and nega-
tive predictive value: 87.7%). We therefore used this
cutoff value to deﬁne eccentric plaque, which was
more frequent in PE than in PR (p < 0.001) or CN
(p ¼ 0.001) (Figure 4A). The majority of culprit






(n ¼ 9) p Value
p Value*
PR vs. PE PE vs. CN PR vs. CN
Lesion location 0.308
LAD 33 (45.8) 18 (60.0) 6 (66.7)
LCX 7 (9.7) 2 (6.7) 0 (0)
RCA 32 (44.4) 10 (33.3) 3 (33.3)
QCA
Reference LD, mm 2.96  0.62 2.96  0.49 2.83  0.46 0.820
MLD, mm 0.27  0.57 0.24  0.44 0.22  0.28 0.953
Percentage of diameter stenosis 91.5  15.9 92.3  13.6 93.0  9.3 0.949
Lesion length, mm 13.4  7.3 13.5  5.4 15.4  7.8 0.716
Type B2/C lesion 55 (76.4) 25 (83.3) 6 (66.7) 0.538
Multivessel disease 31 (43.1) 10 (33.3) 5 (55.6) 0.443
TIMI ﬂow grade 0 49 (68.1) 17 (56.7) 4 (44.4) 0.264
TIMI ﬂow grade # 1 54 (75.0) 22 (73.3) 6 (66.7) 0.863
Bifurcation 11 (15.3) 6 (20.0) 0 (0.0) 0.344
Severe calciﬁcation 1 (1.4) 0 (0.0) 4 (44.4) <0.001 1.000 0.002 <0.001
Thrombectomy 72 (100) 30 (100) 9 (100) 1.000
Stent implantation 72 (100) 28 (93.3) 9 (100) 0.064
Number of stent(s) 1.2  0.5 0.9  0.2 1.1  0.3 0.036 0.010 0.272 0.664
Stent diameter, mm 3.10  0.47 3.27  0.46 3.11  0.49 0.258
Total stent length, mm 25.9  13.5 20.2  5.0 22.8  7.3 0.085
Maximal balloon pressure, atm 16.6  3.5 17.3  3.4 19.6  4.4 0.072
Values are n (%) or mean  SD. *p < 0.017 was considered signiﬁcant.
LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex artery; LD ¼ lumen diameter; MLD ¼ minimal lumen diameter; QCA ¼ quantitative coronary angiography;
RCA ¼ right coronary artery; TIMI ¼ Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.






(n ¼ 9) p Value
p Value*
PR vs. PE PE vs. CN PR vs. CN
Age, yrs 71.0 (60.0, 76.8) 65.0 (59.8, 70.0) 74.0 (71.0, 77.0) 0.037 0.096 0.004 0.209
Male 54 (75.0) 26 (86.7) 9 (100.0) 0.120
Risk factors
Smoking 35 (48.6) 14 (46.7) 2 (22.2) 0.324
Diabetes mellitus 32 (44.4) 8 (26.7) 6 (66.7) 0.070
Dyslipidemia 47 (65.3) 22 (73.3) 6 (66.7) 0.730
Hypertension 51 (70.8) 17 (56.7) 8 (88.9) 0.145
Obesity (BMI >25.0 kg/m2) 32 (44.4) 5 (16.7) 2 (22.2) 0.019 0.012 0.653 0.291
Previous history
Previous MI 3 (4.2) 2 (6.7) 2 (22.2) 0.110
Previous PCI 1 (1.4) 2 (6.7) 1 (11.1) 0.193
Medications
Aspirin 5 (6.9) 1 (3.3) 0 (0) 0.577
ACEI/ARB 21 (29.2) 6 (20.0) 2 (22.2) 0.607
Beta-blocker 6 (8.3) 1 (3.3) 0 (0) 0.460
Calcium channel blocker 28 (38.9) 9 (30.0) 5 (55.6) 0.365
Statin 13 (18.1) 6 (20.0) 2 (22.2) 0.941
Insulin 3 (4.2) 1 (3.3) 0 (0) 0.815
Laboratory ﬁndings
Troponin T, ng/ml 0.21 (0.07, 0.73) 0.08 (0.03, 0.37) 0.81 (0.06, 2.19) 0.130
CK, IU/l 238 (125, 550) 150 (94, 343) 465 (104, 845) 0.146
CK-MB, IU/l 23 (8, 54) 11 (6, 45) 48 (6, 147) 0.250
Onset to reperfusion time, min 397  301 342  240 465  99 0.496
Values are median (25th, 75th percentiles), mean  SD, or n (%). *A p value of <0.017 was considered signiﬁcant.
ACEI ¼ angiotensin-converting enzyme inhibitor; ARB ¼ angiotensin II receptor blocker; BMI ¼ body mass index; CK ¼ creatine kinase; CK-MB ¼ creatine kinase myocardial
band; CN ¼ calciﬁed nodule; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention; PE ¼ plaque erosion; PR ¼ plaque rupture.
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(n ¼ 9) p Value
p Value*
PR vs. PE PE vs. CN PR vs. CN
Fibrous plaque 0 (0) 17 (56.7) 4 (44.4) <0.001 <0.001 0.706 <0.001
Lipid plaque 72 (100) 13 (43.3) 5 (55.6) <0.001 <0.001 0.706 <0.001
Minimum FCT, mm 50 (40, 59) 130 (95, 190) 170 (64, 320) <0.001 <0.001 0.961 0.001
Maximum arc, degrees 360 (298, 360) 211 (168, 285) 154 (102, 312) <0.001 <0.001 0.459 0.005
Length, mm 13.1 (9.1, 17.6) 8.1 (6.8, 9.8) 5.8 (5.0, 12.0) 0.002 <0.001 0.657 0.027
Calciﬁcation 50 (69.4) 15 (50.0) 9 (100) 0.014 0.074 0.007 0.105
Minimum depth,† mm 80 (50, 173) 160 (60, 270) 20 (10, 40) <0.001 0.117 <0.001 <0.001
Maximum arc, degrees 56 (38, 93) 55 (42, 91) 251 (157, 360) <0.001 0.889 <0.001 <0.001
Thrombus score 6.5 (3.0, 13.3) 9.0 (4.0, 15.0) 23.0 (5.5, 32.0) 0.117
Values are n (%) or median (25th, 75th percentiles). *p < 0.017 was considered signiﬁcant. †Minimum depth is measured from the luminal surface to calciﬁcation.
FCT ¼ ﬁbrous cap thickness; OCT ¼ optical coherence tomography; other abbreviations as in Table 1.
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1172PR had positive remodeling, whereas more than
one-half of culprit CN had negative remodeling
(Figures 4B and 4C).
POST-PCI OUTCOME. On angiography, post-procedure
minimal lumen diameter and percentage of diam-
eter stenosis were similar among the 3 groups
(Table 5). Although the incidence of TIMI ﬂow
grade #2 after thrombectomy and after PCI was also
similar among the 3 groups, PE had a lower incidence
of myocardial blush grade #1 and no reﬂow compared
with PR (p ¼ 0.010 and p ¼ 0.011) (Figure 5).
Peak creatine kinase (CK) was higher in PR, but
this difference did not reach statistical signiﬁcance.DISCUSSION
Comprehensive in vivo evaluation of culprit plaque
morphology in patients with acute STEMI wasFIGURE 3 OCT Characteristics of 3 Underlying Mechanisms of STEM
The prevalence of lipid plaque (A) and thin-cap ﬁbroatheroma (TCFA) (B
rupture had a higher prevalence of microchannel (C) than plaque erosion
characteristics between plaque erosion and calciﬁed nodule. A p value operformed using both OCT and IVUS. The main ﬁnd-
ings were: 1) the incidence of PR, PE, and CN in STEMI
was 64.3%, 26.8%, and 8.0%, respectively; 2) PE was
associated with less frequent lipid plaque, smaller
plaque burden, more eccentric plaque, and less
frequent positive remodeling when compared with
PR; 3) CN frequently showed negative remodeling and
superﬁcial large calcium.
INCIDENCE OF UNDERLYING PLAQUE MORPHOLOGIES
IN STEMI. The in vivo diagnosis of PE and CN
has recently been demonstrated using OCT, a high-
resolution imaging modality. PR, PE, and CN have
now been shown in both ex vivo and in vivo studies to
be the primary mechanisms underlying acute coro-
nary thrombosis (1,4). In our previous study, the
incidence of culprit PR, PE, and CN was 44%, 31%,
and 8%, respectively, in patients presenting with ACS
(4). Our current study showed a higher incidence of
PR (64.3%), a discrepancy that may be explained byI
) was higher in plaque rupture than in the other 2 groups. Plaque
. There were no signiﬁcant differences in the frequency of these OCT
f <0.017 was considered signiﬁcant. Abbreviations as in Figure 1.






(n ¼ 9) p Value
p Value*
PR vs. PE PE vs. CN PR vs. CN
Lesion segment
Lumen CSA, mm2 2.9  0.5 3.8  2.6 3.3  1.0 0.015 0.005 0.631 0.017
EEM CSA, mm2 20.5  7.4 19.5  6.1 16.2  4.2 0.112
PþM CSA, mm2 17.7  7.3 15.7  5.6 12.9  4.3 0.196
Plaque burden, % 84.7  4.8 80.2  9.9 78.2  9.0 0.002 0.003 0.580 0.001
Plaque eccentricity index 0.54  0.21 0.71  0.16 0.51  0.09 <0.001 <0.001 <0.001 0.677
Remodeling index 1.21  0.20 1.06  0.29 0.85  0.18 <0.001 0.003 0.056 <0.001
Reference segment
Lumen CSA, mm2 8.0  3.0 8.3  2.7 8.4  3.8 0.851
EEM CSA, mm2 17.2  5.8 18.7  5.2 19.1  3.7 0.343
Values are mean  SD. *p < 0.017 was considered signiﬁcant.
CSA ¼ cross-sectional area; EEM CSA ¼ external elastic membrane; IVUS ¼ intravascular ultrasound; PþM ¼ plaque plus media; other abbreviations as in Table 1.
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1173differences in the study populations. In the previous
study, all ACS patients were included, and the pa-
tients were imaged at various time points. In the
current study, only STEMI patients who presented
within 12 h of symptom onset were included. An
overview of a post-mortem study including sudden
cardiac death and acute myocardial infarction pa-
tients concluded that the incidence of coronary
thrombosis caused by PR was 73% (range 47% to
100%), which is similar to our current results (15). The
incidence of PE in previous autopsy studies ranged
from 25% to 44% (1,16–18), which is also consistent
with our result (26.8%). CN comprised 8.0% of STEMI
presentations in our study; previous autopsy data
showed a similar incidence of CN (4%) (1).
MORPHOLOGIC CHARACTERISTICS OF PLAQUE
EROSION IN STEMI. Previous pathology studies have
reported that PE, compared with PR, had lessFIGURE 4 IVUS Characteristics of 3 Underlying Mechanisms of STEM
Eccentric plaque was more frequent in plaque erosion than in the other
(B), whereas more than one-half of the calciﬁed nodule group had nega
Abbreviations as in Figure 1.“vulnerable” plaque features: smaller size of necrotic
core; less inﬂammatory inﬁltration; fewer number of
vasa vasorum; and lower incidence of positive
remodeling (1,2,18). Our current in vivo intravascular
study similarly demonstrated that culprit PE had
fewer “vulnerable” plaque features than culprit PR
did, including a lower prevalence of lipid plaque and
TCFA, smaller size of lipid core, less frequent micro-
channels, and lower incidence of positive remodel-
ing. In contrast, negative remodeling was more
frequently observed in PE. STEMI caused by PE had
larger lumen CSA and smaller plaque burden at the
culprit lesion site than PR did.
In addition, culprit PE was more eccentric than
culprit PR. Stenotic segments are known to increase
vascular wall shear stress (19), and high shear stress
or sharp gradients at eccentric plaque can induce
platelet adhesion (20). Calciﬁcation in PE has not
been well reported. Only 1 previous pathology studyI
2 groups (A). The majority of plaque rupture had positive remodeling
tive remodeling (C). A p value of <0.017 was considered signiﬁcant.






(n ¼ 9) p Value
p Value*
PR vs. PE PE vs. CN PR vs. CN
Post-thrombectomy
MLD, mm 1.06  0.59 0.89  0.58 0.96  0.42 0.430
Percentage of diameter stenosis 64.4  16.9 70.0  16.0 66.1  13.7 0.307
TIMI ﬂow grade #2 14 (19.4) 5 (16.7) 3 (33.3) 0.541
Post-procedure
MLD, mm 2.62  0.46 2.70  0.57 2.40  0.62 0.328
Percentage of diameter stenosis 13.0  9.5 13.8  11.6 17.0  14.6 0.563
TIMI ﬂow grade #2 15 (20.8) 2 (6.7) 1 (11.1) 0.191
Myocardial blush grade #1 22 (30.6) 2 (6.7) 2 (22.2) 0.034 0.010 0.223 0.719
No reﬂow 28 (38.9) 4 (13.3) 2 (22.2) 0.033 0.011 0.607 0.473
Values are mean  SD or n (%). *A p value of <0.017 was considered signiﬁcant.
Abbreviations as in Tables 1 and 2.
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1174showed the incidence of calciﬁcation to be around
60% in eroded plaques (21). Our study showed a
similar incidence (54.3%). Although no signiﬁcant
difference was seen in the prevalence and size of
calciﬁcation between PE and PR, the location of
calciﬁcation was deeper in PE.
MORPHOLOGIC CHARACTERISTICS OF CALCIFIED
NODULE IN STEMI. In our series, only 9 cases (8.0%)
of STEMI were caused by CN. However, these cases
showed characteristic morphologic features. First,
most of CN contained superﬁcially located large
calciﬁcation, which is termed pathologically as a
“calcium sheet” (15,22). A previous IVUS study vali-
dated by histology similarly showed that superﬁcial
calcium was among the key ﬁndings of CN, although
the depth of calcium in the vessel wall was not
assessed (23). Although large calcium in CN might beFIGURE 5 Acute Outcomes After Primary PCI
Plaque erosion was associated with better outcomes than plaque rupture
and no reﬂow than plaque rupture did (A, B). There was a trend toward h
other groups (C). A p value of <0.017 was considered signiﬁcant. PCI ¼affected by the deﬁnition of CN in this study, the
histology study showed that the possible mechanism
of CN is a break of calcium sheet into the lumen. Our
ﬁnding, therefore, is in line with histology (2). Second,
negative remodeling was most frequent in CN than in
PR and PE. Lumen CSA was similar between CN and
PR, but CN was more constrictive. These ﬁndings
might suggest CN had smaller plaque burden than PR.
Third, CN occurred more frequently in elderly pa-
tients. Our data are therefore consistent with the
ﬁndings from a previous IVUS study which reported
that negative remodeling and large-size calciﬁcation
without plaque rupture were frequently seen in older
acute myocardial infarction patients (24).
ACUTE OUTCOMES AFTER PRIMARY PCI. In our
previous OCT study of patients with ACS, PR was
more frequently identiﬁed in patients presenting. Plaque erosion had a lower incidence of myocardial blush grade #1
igher peak creatine kinase (CK) elevation in plaque rupture than in the
percutaneous coronary intervention.
PERSPECTIVES
WHAT IS KNOWN? OCT enables us to diagnose PE and CN
in vivo. The incidence and morphologic characteristics of PR, PE,
and CN in patients with STEMI as well as the outcomes after
primary PCI have been unknown.
WHAT IS NEW? This study reports that the incidence of PR, PE,
and CN in STEMI is 64.3%, 26.8%, and 8.0%, respectively. The
culprit lesions with PR have higher prevalence of TCFA, micro-
channel, and positive remodeling. Those with PE have higher
prevalence of ﬁbrous eccentric plaque. Those with CN have su-
perﬁcial calcium sheets and negative remodeling. PR results in
worse outcome following PCI.
WHAT IS NEXT? The ﬁndings of this study will help to expand
the understanding of the underlying patho-physiology and to
develop optimal therapeutic strategies of STEMI. The role of OCT
in optimizing PCI requires further study in large-scale prospec-
tive trials.
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1175with STEMI than in those presenting with non–
ST-segment elevation ACS (4). This ﬁnding suggests
that PR may be associated with a larger infarct size
than PE or CN are. A previous IVUS and angioscopy
study (25) in AMI patients showed that PR was
associated with higher peak CK level after primary
PCI than PE, although neither IVUS nor angioscopy
are ideal for diagnosing PE (3). In the current study
of STEMI patients, PR was associated with worse
myocardial perfusion than PE. Ruptured site re-
leases highly thrombogenic substrates such as lipid
and tissue factor (26), which may induce recurrent
local thrombosis and distal embolization, perturbing
the coronary microcirculation. In addition, it was
reported that TCFA was associated with microvas-
cular obstruction after PCI (27). Indeed, the
increased incidence of no reﬂow was mainly driven
by the increased incidence of myocardial blush
grade #1. Despite a trend toward a higher peak CK
in PR, the difference in peak CK among the 3 groups
did not reach statistical signiﬁcance. The use of
aggressive manual thrombectomy to remove a large
amount of thrombus may have minimized potential
differences in myocardial injury among the 3
groups.
STUDY LIMITATIONS. Although this is the ﬁrst sys-
tematic in vivo study of the culprit lesion in patients
with STEMI using both OCT and IVUS, there are several
limitations that should be acknowledged. First, this
was a single-center study, and the analysis was done
retrospectively. Second, thrombectomy was per-
formed to facilitate reperfusion prior to intravascular
imaging. Although care was taken to avoid excessive
mechanical trauma during thrombectomy, it is
possible that this procedure may have altered the
morphologic features of the underlying plaque. Third,
residual thrombus can limit the accurate evaluation of
OCT images. We therefore excluded patients with sig-
niﬁcant residual thrombus from analysis. Fourth,
the OCT deﬁnition of PE is in some ways a diagnosis
of exclusion, requiring the absence of ﬁbrous
cap disruption or superﬁcial calcium underlying
thrombus. The absence of an endothelial lining is a key
criterion for the pathological diagnosis of PE. Despite
the highest resolution among available intravascular
imaging modalities, the current OCT system does not
have a high enough resolution to visualize endothelial
cells. Fifth, IVUS evaluation in the presence of
thrombus or heavy calciﬁcation is still challenging.
Several previous IVUS studies, however, have shown
the efﬁcacy of IVUS evaluation in the coronary arteries
in patients with STEMI cases (28,29) or heavily calci-
ﬁed lesions (24). Our results are similar to the results ofthose studies. Sixth, although the reperfusion time
was relatively longer in our study than in the previ-
ously published study (28), the reperfusion time
was not different among the 3 groups (397 301 min in
PR, 342  240 min in PE, and 465  99 min in CN;
p ¼ 0.496). Finally, the number of CN cases was
small. Further studies of larger size are required to
investigate this subgroup. Our result, however, is in
line with previous pathology studies showing a low
incidence of CN.
CONCLUSIONS
This study demonstrates that PR, PE, and CN were the
underlying mechanisms in 64.3%, 26.8%, and 8.0% of
patients with STEMI, respectively. PE was character-
ized by eccentric ﬁbrous plaque with fewer features
of plaque vulnerability. CN was characterized by
superﬁcial calcium sheets and negative remodeling.
PE was associated with less microvascular damage
after PCI.
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